by Brooks Hays
Washington (UPI) Aug 8, 2017
Scientists have created a variety of medicines using compounds discovered in the venoms of snakes, frogs, snails, jellyfish and other animals.
New research suggests lizard venoms could serve as an untapped source of medicinal compounds. Specifically, scientists at the University of Queensland believe lizard venoms could yield new treatments for blood clots.
Research into lizard venoms is relatively new. Until recently, biologists thought only a few lizards were venomous. But a number of new studies have revealed a surprisingly large number of venomous lizard species.
"We now know that far more lizards are venomous than previously thought, including the iconic Komodo dragon -- the world's largest lizard," Bryan Fry, an assistant professor at QU, said in a news release.
Fry and his colleagues have spent much time in the lab analyzing the venoms of 16 monitor lizard species, including the Komodo dragon. Their analysis has identified a number of novel compounds with potential for use in the treatment of strokes.
"By investigating the actions of lizard venoms, we can potentially use them to disrupt life-threatening blood clots, and turn these compounds into life-saving drugs," Fry said.
Lab tests suggest monitor lizard venoms can target fibrinogen, a protein important to blood clot formation.
"It is this specialized targeting that has made similar snake venom enzymes so successful in treating blood diseases," Fry said.
Researchers detailed their analysis of monitor lizard venoms this week in the journal Toxins.
Nagoya, Japan (SPX) Jul 31, 2017
The sorting of individual cells is necessary for many biological applications, including the isolation of specific cell types from cell suspensions. A fluorescence-activated cell sorting (FACS) has been used for high-throughput cell sorting. In this method, lasers are used to excite auto-fluorescence or tagged-fluorescence of cell included in droplets, and then droplets are diverted into differe ... read more
Hospital and Medical News at InternDaily.com
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2017 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement|